HDAC3 is critical in tumor development and therapeutic resistance in <i>Kras</i> -mutant non–small cell lung cancer

Lillian J. Eichner(Northwestern University), Reuben J. Shaw(Salk Institute for Biological Studies)
Science Advances
March 17, 2023
Cited by 71


Related Papers